These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11213560)

  • 21. The effect of a jail methadone maintenance therapy (MMT) program on inmate recidivism.
    McMillan GP; Lapham S; Lackey M
    Addiction; 2008 Dec; 103(12):2017-23. PubMed ID: 19469745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population size estimation in a two-list surveillance system with a discrete covariate.
    You N; Xuan Mao C
    Biometrics; 2008 Jun; 64(2):371-6. PubMed ID: 18325071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality of life among heroin users on buprenorphine versus methadone maintenance.
    Ponizovsky AM; Grinshpoon A
    Am J Drug Alcohol Abuse; 2007; 33(5):631-42. PubMed ID: 17891656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erectile dysfunction in male heroin users, receiving methadone and buprenorphine maintenance treatment.
    Quaglio G; Lugoboni F; Pattaro C; Melara B; ; Mezzelani P; Des Jarlais DC;
    Drug Alcohol Depend; 2008 Apr; 94(1-3):12-8. PubMed ID: 18083312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term outcomes of treatment-resistant heroin addicts with and without DSM-IV axis I psychiatric comorbidity (dual diagnosis).
    Maremmani I; Pacini M; Lubrano S; Perugi G; Tagliamonte A; Pani PP; Gerra G; Shinderman M
    Eur Addict Res; 2008; 14(3):134-42. PubMed ID: 18552489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methadone maintenance in prison: evaluation of a pilot program in Puerto Rico.
    Heimer R; Catania H; Newman RG; Zambrano J; Brunet A; Ortiz AM
    Drug Alcohol Depend; 2006 Jun; 83(2):122-9. PubMed ID: 16332415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for alcohol use patterns among methadone maintenance patients.
    Teplin D; Raz B; Daiter J; Varenbut M; Plater-Zyberk C
    Am J Drug Alcohol Abuse; 2007; 33(1):179-83. PubMed ID: 17366259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methadone maintenance treatment can be provided in a primary care setting without increasing methadone-related mortality: the Sheffield experience 1997-2000.
    Keen J; Oliver P; Mathers N
    Br J Gen Pract; 2002 May; 52(478):387-9. PubMed ID: 12014536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methadone maintenance treatment: the balance between life-saving treatment and fatal poisonings.
    Fugelstad A; Stenbacka M; Leifman A; Nylander M; Thiblin I
    Addiction; 2007 Mar; 102(3):406-12. PubMed ID: 17298648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does pregnancy affect outcome of methadone maintenance treatment?
    Crandall C; Crosby RD; Carlson GA
    J Subst Abuse Treat; 2004 Jun; 26(4):295-303. PubMed ID: 15182894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients.
    Maremmani I; Pani PP; Pacini M; Perugi G
    J Subst Abuse Treat; 2007 Jul; 33(1):91-8. PubMed ID: 17588494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Capture-recapture and multiple-record systems estimation I: History and theoretical development. International Working Group for Disease Monitoring and Forecasting.
    Am J Epidemiol; 1995 Nov; 142(10):1047-58. PubMed ID: 7485050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Affective temperaments in heroin addiction.
    Maremmani I; Pacini M; Popovic D; Romano A; Maremmani AG; Perugi G; Deltito J; Akiskal K; Akiskal H
    J Affect Disord; 2009 Oct; 117(3):186-92. PubMed ID: 19201034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mortality in heroin users 3 years after naltrexone implant or methadone maintenance treatment.
    Tait RJ; Ngo HT; Hulse GK
    J Subst Abuse Treat; 2008 Sep; 35(2):116-24. PubMed ID: 17931824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancing the quality of nursing care in methadone substitute clinics using action research: a process evaluation.
    Loth C; Schippers GM; Hart H; van de Wijngaart G
    J Adv Nurs; 2007 Feb; 57(4):422-31. PubMed ID: 17291206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An industrial workshop for heroin addicts.
    Raynes AE; Fisch A; Levine ME; McKenna GJ; Patch VD
    Proc Natl Conf Methadone Treat; 1973; 2():1044-7. PubMed ID: 4808245
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of a new drug in the treatment of heroin addicts should not be obstructed by political dogmatism].
    Heilig M; Nilsson LH; Grönbladh L; Thulin SO; Sternebring B
    Lakartidningen; 2001 Sep; 98(37):3956-8. PubMed ID: 11586837
    [No Abstract]   [Full Text] [Related]  

  • 38. Glucocorticoid negative feedback in methadone-maintained former heroin addicts with ongoing cocaine dependence: dose-response to dexamethasone suppression.
    Aouizerate B; Ho A; Schluger JH; Perret G; Borg L; Le Moal M; Piazza PV; Kreek MJ
    Addict Biol; 2006 Mar; 11(1):84-96. PubMed ID: 16759341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS).
    Ross J; Teesson M; Darke S; Lynskey M; Ali R; Ritter A; Cooke R
    Drug Alcohol Rev; 2005 Sep; 24(5):411-8. PubMed ID: 16298835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dutch courage.
    Sheldon T
    Nurs Times; 1999 Mar 3-9; 95(9):38-40. PubMed ID: 10196989
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.